Cyrielle Aveline

CNM_220647 394..401

P. Chanson, S. Christin‐Maitre, F. Montravers, 2022 .

Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study

O. Cussenot, I. Durand-zaleski, F. Lecouvet, 2018, World Journal of Urology.

68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

O. Cussenot, J. Talbot, F. Montravers, 2020, Scientific Reports.

Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT, illustrative cases and pitfalls.

J. Talbot, F. Montravers, S. Périé, 2022, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France

Frédéric Lecouvet, Kevin Zarca, Olivier Cussenot, 2020, BMC Medical Imaging.

18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center.

J. Haymann, J. Talbot, S. Christin‐Maitre, 2023, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....